<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The weights of the spleens of series of patients with various disorders of children dating from birth or early infancy and causing <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, with or without <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> of the liver, were analyzed </plain></SENT>
<SENT sid="1" pm="."><plain>The linear regression equation for spleen weight versus age in months for each disease was derived, and the rate constants from these equations were adjusted for the age range of the patients in each group </plain></SENT>
<SENT sid="2" pm="."><plain>The original data of Coppoletta and Wolbach were used for <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="3" pm="."><plain>The rates of splenic growth of appropriate entities for which the regression equation could be computed fell into three groups, with adjusted rate constants (growth of spleen in grams per month) of 6.53-6.95 (<z:hpo ids='HP_0005912'>biliary atresia</z:hpo>, <z:e sem="disease" ids="C0039730" disease_type="Disease or Syndrome" abbrv="">thalassemia</z:e>, and <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> following neonatal <z:hpo ids='HP_0012115'>hepatitis</z:hpo>), 2.30-2.62 (<z:hpo ids='HP_0001394'>cirrhosis</z:hpo> of <z:e sem="disease" ids="C0221757" disease_type="Disease or Syndrome" abbrv="">alpha-1-antitrypsin deficiency</z:e>, infantile <z:mpath ids='MPATH_586'>polycystic disease</z:mpath>, and <z:hpo ids='HP_0004444'>spherocytosis</z:hpo>), and 1.06-1.11 (cystic <z:mp ids='MP_0003045'>fibrosis</z:mp> and <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>These classes of splenic growth rates are approximately 10, 3.7, and 1.6 times the <z:mpath ids='MPATH_458'>normal</z:mpath> growth rate (0.67 g/mo) </plain></SENT>
<SENT sid="5" pm="."><plain>Rate constants could not be computed for the categories <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> following <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo> and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> other than <z:hpo ids='HP_0004444'>spherocytosis</z:hpo> and sickle cell <z:hpo ids='HP_0001903'>anemia</z:hpo>, and the numbers of patients with splenic vein obstruction, <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> with the cholestatic syndrome of parenteral alimentation, <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> with <z:mp ids='MP_0005639'>hemosiderosis</z:mp>, <z:hpo ids='HP_0003231'>tyrosinemia</z:hpo>, Byler's disease, <z:hpo ids='HP_0002612'>congenital hepatic fibrosis</z:hpo>, and <z:e sem="disease" ids="C0019202" disease_type="Disease or Syndrome" abbrv="WD|WND">Wilson's disease</z:e> were too few for analysis </plain></SENT>
<SENT sid="6" pm="."><plain>The significance of the finding of classes or "quantum groups" of splenic growth rates in disorders of children, dating from birth or early infancy and causing <z:hpo ids='HP_0001744'>splenomegaly</z:hpo>, is uncertain </plain></SENT>
<SENT sid="7" pm="."><plain>Comparable data on adequate series of patients with other appropriate disorders will be necessary </plain></SENT>
</text></document>